Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Enters into $6.2M Purchase Agreement for the Sale of Australian Facility

Canada NewsWire July 11, 2022

MediPharm Labs Announces Voting Results From the 2022 Annual Meeting of Shareholders

PR Newswire June 30, 2022

MediPharm Labs Reports First Quarter Results

PR Newswire May 16, 2022

MediPharm Labs Sets Date to Report First Quarter 2022 Financial Results

PR Newswire May 12, 2022

MediPharm Labs Names Experienced Pharma and Med Tech Executive David Pidduck, as CEO

PR Newswire April 20, 2022

The StockTalk Cannabis Report: April 8, 2022

Dave Jackson April 8, 2022

MediPharm Labs Continues to Lead with Innovation - Launches CBG and Water-Soluble Products

PR Newswire April 5, 2022

MediPharm Labs Reports Fourth Quarter and Full Year 2021 Results

PR Newswire March 31, 2022

MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2021 Financial Results

PR Newswire March 29, 2022

MediPharm Labs Strengthens Recreational Business Adding Flower and Pre-Rolls to Portfolio - Acquires IP from Canadian Consumer Favourite, Shelter Cannabis Brands

PR Newswire March 22, 2022

The StockTalk Cannabis Report: Mar 11, 2022

Dave Jackson March 11, 2022

MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF

PR Newswire February 23, 2022

The StockTalk Cannabis Report: Jan 28, 2022

Dave Jackson January 28, 2022

MediPharm Labs Completes Payment of All Convertible Debt

GlobeNewswire January 5, 2022

MediPharm Labs (TSX:LABS) receives CBD Brand of the Year award from KIND Magazine

John Ballem  December 22, 2021

MediPharm Labs Receives Award for CBD Brand of the Year

GlobeNewswire December 22, 2021

MediPharm Labs Provides Operational Update and Confirms Profitability Improvement Initiatives are Underway

GlobeNewswire December 21, 2021

MediPharm Labs Announces Changes to Board of Directors

GlobeNewswire December 7, 2021

MediPharm Labs (TSX:LABS) announces medical cannabis delivery to Barbados

John Ballem  November 26, 2021